Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Explore wealth building strategies specifically designed for beginners. These tips will help you start your financial journey on the right foot.
15,461 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
As Nvidia's earnings loom, Polkadot and Solana are steering the crypto markets higher. This guide explains why these ...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...
A solid move by a seasoned fund—Alpine Capital Research increases its Arrow Electronics position. Learn what this cou...
Qualcomm nudges the industry toward 6G with a bold roadmap. Investors are weighing the potential for faster networks ...
Dive into veeva (veev) 2026 earnings with a close look at Q4 results, guidance, and what the numbers mean for investo...
As yields rise in early 2026, retirees are reallocating a $500,000 portfolio toward income-focused assets to secure s...
As volatility persists in 2026, a small-cap dividend ETF is drawing renewed interest from retirees seeking steady inc...
Lucid Group has ambitious plans, but shifting from carmaker to tech supplier brings new risks. This article explains ...
Tech ETFs offer fast access to the U.S. tech sector, but costs and portfolio makeup vary. This guide breaks down the ...
Waymo’s leadership argues that robotaxis will reframe work rather than eliminate it, highlighting maintenance, fleet ...